Aifm1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Apoptosis-Inducing Factor 1 | |
|---|---|
| Gene Symbol | AIFM1 |
| Full Name | Apoptosis-Inducing Factor 1, Mitochondrial |
| Chromosome | Xq26.1 |
| NCBI Gene ID | 513 |
| OMIM | 300169 |
| Ensembl ID | ENSG00000156509 |
| UniProt ID | O95331 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, X-linked Axonal Neuropathy, Cowchock Syndrome |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
AIFM1 (Apoptosis-Inducing Factor 1) is a flavoprotein located in the mitochondrial intermembrane space that functions in both normal mitochondrial metabolism and programmed cell death. Under normal conditions, AIF functions as a NADH oxidoreductase, contributing to mitochondrial electron transport chain function. During apoptosis, AIF is released from mitochondria into the cytosol and then translocates to the nucleus, where it triggers large-scale DNA fragmentation in a caspase-independent manner.
AIF-mediated cell death is distinct from the classical caspase-dependent apoptosis pathway. AIF release is often triggered by severe cellular stress including oxidative damage, calcium overload, and ATP depletion. Once in the nucleus, AIF recruits endonucleases like ENDOG to cause DNA degradation.
AIFM1 is widely expressed in many tissues, with high expression in metabolically active tissues including heart, brain, and liver. It is anchored to the inner mitochondrial membrane. Its expression is essential for embryonic development.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Altered expression | Acquired | AIF translocation contributes to neuronal DNA damage |
| Parkinson's Disease | Altered expression | Acquired | AIF-mediated cell death in dopaminergic neurons |
| Cowchock Syndrome | Loss-of-function | X-linked | Severe axonal neuropathy with neurodegeneration |
| X-linked Axonal Neuropathy | Mutations | X-linked | Progressive motor and sensory neuropathy |
The study of Aifm1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.